Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner
about
Oligonucleotide therapeutic approaches for Huntington diseaseLong non-coding RNAs in nervous system function and disease5-Hydroxymethylcytosine: A new player in brain disorders?Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasisHuntingtin Is Required for Epithelial Polarity through RAB11A-Mediated Apical Trafficking of PAR3-aPKCSIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesisEnhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila modelGenome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's diseaseA potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease.Prions, amyloids, and RNA: Pieces of a puzzle.Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysisStriatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's diseaseGenome wide gene expression regulation by HIP1 Protein Interactor, HIPPI: prediction and validationImpairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation.Differential nuclear localization of complexes may underlie in vivo intrabody efficacy in Huntington's disease.Promoters are differentially sensitive to N-terminal mutant huntingtin-mediated transcriptional repression.Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease.A common gene expression signature in Huntington's disease patient brain regions.In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons.Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease.Comparison of modules of wild type and mutant Huntingtin and TP53 protein interaction networks: implications in biological processes and functions.Huntington disease (chorea) in the middle East.Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease.Grb2 is regulated by foxd3 and has roles in preventing accumulation and aggregation of mutant huntingtinTranscription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspectiveDevelopment of an ELISA assay for the quantification of soluble huntingtin in human blood cells.Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.Expanded polyglutamine-binding peptoid as a novel therapeutic agent for treatment of Huntington's disease.Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington's DiseaseMutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington's Disease T Lymphocytes.Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.Polyglutamine (polyQ) disorders: the chromatin connection.Extensive changes in DNA methylation are associated with expression of mutant huntingtin.Expression of RNAs Coding for Metal Transporters in Blood of Patients with Huntington's DiseaseAn Intrabody Drug (rAAV6-INT41) Reduces the Binding of N-Terminal Huntingtin Fragment(s) to DNA to Basal Levels in PC12 Cells and Delays Cognitive Loss in the R6/2 Animal ModelRegulation of non-coding RNA networks in the nervous system--what's the REST of the story?Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.MeCP2: a novel Huntingtin interactor.
P2860
Q22306293-D0AF2BED-D10B-4C53-8DB5-E6F1E3AA3AE1Q24595656-E13B3F2D-7955-425E-8408-AC0B4EA23F8FQ26853292-260B93B6-775E-4780-A0CC-B8985EB2B286Q27026549-CF7BE00B-127C-464B-B8E4-10440BD4A0CEQ27312162-EEA80630-49EF-4C6C-8EED-D39AC6DBF4D6Q28279273-24DBF619-36B9-4B56-8318-759379980301Q28389710-8299BBB7-821C-4F34-B6AF-A8B7D8EE6B11Q28594357-AF224ED5-40AC-47F6-9BF1-55ED29AECF5CQ30578694-91093206-16B6-46E3-A51F-300005E05918Q33363261-AD98844A-C95F-4A4B-A7BE-AB1118B3D594Q33713689-1E226406-761B-41EF-BCF0-1E0A51C3436CQ33755822-7542166E-4294-4AED-9261-2994BF03F7DDQ33831774-5731C835-4C6B-4260-8350-63BF6DF91EECQ34009621-9DAF5BD9-EBDF-48AD-9F31-8DC015C6C267Q34029504-7777726E-FD90-47DB-A866-4807CCFDC051Q34042260-39D85F3B-8291-47EE-B536-A040E6FFA895Q34313192-3B852CEE-8033-4BB6-B51C-7D000BD4D08DQ34345722-32068ADF-10A8-44A4-B6BF-8F5E4A6EE6A7Q34358457-0A3BF091-3A34-48D9-A249-26F7A7F14463Q34446889-13A04874-9FAD-4F60-97C5-46D714942908Q34597796-9548FC98-508E-42A2-82A0-E2F6E2780DA7Q34743269-067A4FE9-87EA-4E9D-8818-0595A301BB13Q34760892-3B39205D-FA1A-4CD6-BB37-B6D8F1051AB4Q34782712-096E50FF-7BC3-41A8-B439-7550E3DC3AFDQ34829422-CC30A17D-3D67-4B14-A8B5-F6122BB0DA27Q35014895-423917E1-BC8E-4045-93CE-B8AA2F3D1132Q35024695-B56AF08D-7C21-4C41-A2AB-156DBC527B1DQ35052612-0D34478F-D10E-4ACB-89F7-E465A221C21AQ35208420-FE8A49C1-E57B-49DE-AF81-A762F7DA4C87Q35244160-D246AA75-9A2B-4BD8-8A65-96F9EDCB1B93Q35542530-34AFA1A8-77F8-4BA1-8EF9-E40C1F4C4C0EQ35830504-A5F0BB26-18AD-412C-A152-B2FC50F016D5Q35867566-A64C0A4C-DF7C-47F1-811E-331FE72EA32DQ36328114-0B495B23-AC5B-4714-99A2-CF6313B826DEQ36598186-6FB57EC0-1784-4CA4-8A9F-85435130D362Q36637306-5CBE8BA7-9C9F-481A-96B9-2BEAE8116032Q37198517-DF077CB6-6A12-443D-9102-BBF2E8BE94D4Q37399818-4623B0B3-E67C-4830-9B35-B3FFE0F6770BQ37466088-9EFC9E69-025E-4BF8-A9C8-9CF84C16D6B8Q37508593-A1DD5A5A-E39F-46D6-B7E4-E6CBC7FDF52B
P2860
Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Huntingtin modulates transcrip ...... polyglutamine-dependent manner
@en
type
label
Huntingtin modulates transcrip ...... polyglutamine-dependent manner
@en
prefLabel
Huntingtin modulates transcrip ...... polyglutamine-dependent manner
@en
P2093
P2860
P50
P1476
Huntingtin modulates transcrip ...... polyglutamine-dependent manner
@en
P2093
Caroline L Benn
Derek P DiRocco
George J Yohrling
Jang-Ho J Cha
Karen N McFarland
Tingting Sun
P2860
P304
10720-10733
P356
10.1523/JNEUROSCI.2126-08.2008
P407
P577
2008-10-01T00:00:00Z